Lv41
720 积分 2020-12-26 加入
Clinical and laboratory features of 244 men with primary syphilis: a 5-year single-centre retrospective study
2小时前
求助中
Lung infections after cancer chemotherapy
21天前
已完结
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
1个月前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
2个月前
已完结
AdEPro: Animation of Adverse Event Profiles—Presentation of an Easy-to-Use App for Visually Exploring Individual Study Data
2个月前
已完结
Utilizing temporal pattern of adverse event reports to identify potential late-onset adverse events
2个月前
已完结
TUB-040, a homogenous and hydrophilic NaPi2b-targeting ADC with stably linked exatecan, exhibits long-lasting anti-tumor activity and a well-tolerated safety profile
2个月前
已完结
A phase 1 study of XMT-1536 in patients with solid tumors likely to express NaPi2b: A summary of dose escalation
3个月前
已完结
Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer
3个月前
已完结
皖公网安备34019202002308
